MMSI Quote, Financials, Valuation and Earnings

Becton Dickinson & has a net margin of 7.87% compared to Merit Medical Systems's net margin of 5.86%. Merit Medical Systems's return on equity of 9.36% beat Becton Dickinson &'s return on equity of 6.75%.

Merit Medical Systems has a consensus price target of $118.20, signalling upside risk potential of 19.47%. On the other hand Becton Dickinson & has an analysts' consensus of $276.77 which suggests that it could grow by 22.48%. Given that Becton Dickinson & has higher upside potential than Merit Medical Systems, analysts believe Becton Dickinson & is more attractive than Merit Medical Systems.

Merit Medical Systems has a beta of 0.914, which suggesting that the stock is 8.607% less volatile than S&P 500. In comparison Becton Dickinson & has a beta of 0.355, suggesting its less volatile than the S&P 500 by 64.526%.

Merit Medical Systems has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Becton Dickinson & offers a yield of 1.76% to investors and pays a quarterly dividend of $1.04 per share. Merit Medical Systems pays -- of its earnings as a dividend. Becton Dickinson & pays out 64.52% of its earnings as a dividend. Becton Dickinson &'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Merit Medical Systems quarterly revenues are $355.2M, which are smaller than Becton Dickinson & quarterly revenues of $5.2B. Merit Medical Systems's net income of $27.9M is lower than Becton Dickinson &'s net income of $303M. Notably, Merit Medical Systems's price-to-earnings ratio is 48.74x while Becton Dickinson &'s PE ratio is 37.54x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Merit Medical Systems is 4.33x versus 3.18x for Becton Dickinson &. Usually stocks with elevated PS ratios are considered overvalued.

Boston Scientific has a net margin of 7.87% compared to Merit Medical Systems's net margin of 12.41%. Merit Medical Systems's return on equity of 9.36% beat Boston Scientific's return on equity of 8.96%.

Merit Medical Systems has a consensus price target of $118.20, signalling upside risk potential of 19.47%. On the other hand Boston Scientific has an analysts' consensus of $115.62 which suggests that it could grow by 19%. Given that Merit Medical Systems has higher upside potential than Boston Scientific, analysts believe Merit Medical Systems is more attractive than Boston Scientific.

Merit Medical Systems has a beta of 0.914, which suggesting that the stock is 8.607% less volatile than S&P 500. In comparison Boston Scientific has a beta of 0.772, suggesting its less volatile than the S&P 500 by 22.845%.

Merit Medical Systems has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Boston Scientific offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Merit Medical Systems pays -- of its earnings as a dividend. Boston Scientific pays out -- of its earnings as a dividend.

Merit Medical Systems quarterly revenues are $355.2M, which are smaller than Boston Scientific quarterly revenues of $4.6B. Merit Medical Systems's net income of $27.9M is lower than Boston Scientific's net income of $566M. Notably, Merit Medical Systems's price-to-earnings ratio is 48.74x while Boston Scientific's PE ratio is 77.73x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Merit Medical Systems is 4.33x versus 8.62x for Boston Scientific. Usually stocks with elevated PS ratios are considered overvalued.

ICU Medical has a net margin of 7.87% compared to Merit Medical Systems's net margin of -3.78%. Merit Medical Systems's return on equity of 9.36% beat ICU Medical's return on equity of -5.75%.

Merit Medical Systems has a consensus price target of $118.20, signalling upside risk potential of 19.47%. On the other hand ICU Medical has an analysts' consensus of $190.00 which suggests that it could grow by 32.66%. Given that ICU Medical has higher upside potential than Merit Medical Systems, analysts believe ICU Medical is more attractive than Merit Medical Systems.

Merit Medical Systems has a beta of 0.914, which suggesting that the stock is 8.607% less volatile than S&P 500. In comparison ICU Medical has a beta of 0.733, suggesting its less volatile than the S&P 500 by 26.693%.

Merit Medical Systems has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. ICU Medical offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Merit Medical Systems pays -- of its earnings as a dividend. ICU Medical pays out -- of its earnings as a dividend.

Merit Medical Systems quarterly revenues are $355.2M, which are smaller than ICU Medical quarterly revenues of $629.8M. Merit Medical Systems's net income of $27.9M is higher than ICU Medical's net income of -$23.8M. Notably, Merit Medical Systems's price-to-earnings ratio is 48.74x while ICU Medical's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Merit Medical Systems is 4.33x versus 1.47x for ICU Medical. Usually stocks with elevated PS ratios are considered overvalued.

Masimo has a net margin of 7.87% compared to Merit Medical Systems's net margin of -58.2%. Merit Medical Systems's return on equity of 9.36% beat Masimo's return on equity of -23.05%.

Merit Medical Systems has a consensus price target of $118.20, signalling upside risk potential of 19.47%. On the other hand Masimo has an analysts' consensus of $193.76 which suggests that it could grow by 15.19%. Given that Merit Medical Systems has higher upside potential than Masimo, analysts believe Merit Medical Systems is more attractive than Masimo.

Merit Medical Systems has a beta of 0.914, which suggesting that the stock is 8.607% less volatile than S&P 500. In comparison Masimo has a beta of 1.035, suggesting its more volatile than the S&P 500 by 3.537%.

Merit Medical Systems has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Masimo offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Merit Medical Systems pays -- of its earnings as a dividend. Masimo pays out -- of its earnings as a dividend.

Merit Medical Systems quarterly revenues are $355.2M, which are smaller than Masimo quarterly revenues of $600.7M. Merit Medical Systems's net income of $27.9M is higher than Masimo's net income of -$349.6M. Notably, Merit Medical Systems's price-to-earnings ratio is 48.74x while Masimo's PE ratio is 116.80x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Merit Medical Systems is 4.33x versus 4.35x for Masimo. Usually stocks with elevated PS ratios are considered overvalued.